Search research articles
Contact Us
Filters
Showing results (751-760 of 819) with videos related to
Page
of 82
Sort By:
Nature
|
October 14, 2008
Generation of pluripotent stem cells from adult human testis
Sabine Conrad, Markus Renninger, Jörg Hennenlotter, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 16, 2014
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
M Vogelhuber, S Feyerabend, A Stenzl, et al.
Urologic Oncology
|
October 23, 2022
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria
Eva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, et al.
European Urology
|
July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy
Alexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
Urologic Oncology
|
February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer
Natalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
The Lancet. Oncology
|
March 12, 2017
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
Kim N Chi, Celestia S Higano, Brent Blumenstein, et al.
Clinical and Translational Medicine
|
June 9, 2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
Anna Reustle, Lena-Sophie Menig, Patrick Leuthold, et al.
World Journal of Urology
|
January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer
Jeffrey J Leow, Jens Bedke, Karim Chamie, et al.
Cancers
|
June 2, 2021
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)
Philip Zeuschner, Sebastian Hölters, Michael Stöckle, et al.
European Urology
|
January 14, 2015
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel
Timothy G Wilson, Khurshid Guru, Raymond C Rosen, et al.
Page
of 82
Search research articles
Search
Showing results (751-760 of 819) with videos related to
Sort By:
Page
of 82
Nature
|
October 14, 2008
Generation of pluripotent stem cells from adult human testis
Sabine Conrad, Markus Renninger, Jörg Hennenlotter, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 16, 2014
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
M Vogelhuber, S Feyerabend, A Stenzl, et al.
Urologic Oncology
|
October 23, 2022
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria
Eva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, et al.
European Urology
|
July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy
Alexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
Urologic Oncology
|
February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer
Natalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
The Lancet. Oncology
|
March 12, 2017
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
Kim N Chi, Celestia S Higano, Brent Blumenstein, et al.
Clinical and Translational Medicine
|
June 9, 2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
Anna Reustle, Lena-Sophie Menig, Patrick Leuthold, et al.
World Journal of Urology
|
January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer
Jeffrey J Leow, Jens Bedke, Karim Chamie, et al.
Cancers
|
June 2, 2021
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)
Philip Zeuschner, Sebastian Hölters, Michael Stöckle, et al.
European Urology
|
January 14, 2015
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel
Timothy G Wilson, Khurshid Guru, Raymond C Rosen, et al.
Page
of 82